Preferred test to follow-up presumptive results. For general screening, Cocaine, Urine with Reflex to Quantitation (2012231) is preferred.
Quantitative Gas Chromatography-Mass Spectrometry/Quantitative Liquid Chromatography-Tandem Mass Spectrometry
New York DOH Approval Status
Transfer 3.5 mL urine with no additives or preservatives to an ARUP Standard Transport Tube. (Min: 1.5 mL)
Specimens exposed to repeated freeze/thaw cycles.
Ambient: 1 week; Refrigerated: 1 month; Frozen: 3 years
Effective August 17, 2015
|Drugs Covered||Cutoff Concentrations|
Methodology: Quantitative Gas Chromatography-Mass Spectrometry/Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Positive cutoff: 50 ng/mL
For medical purposes only; not valid for forensic use.
The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
Compare to Pain Management, Cocaine Metabolite with Confirmation with medMATCH, Urine; Pain Management, Cocaine Metabolite, Quantitative, with medMATCH, Urine.
80353 (Alt code: G0480)
|Component Test Code*||Component Chart Name||LOINC|
|0090359||Benzoylecgonine, Urn, Quant||3394-4|
- Pain Management